New hope for stubborn arthritis: drug trial targets unresponsive cases
Disease control
Ongoing
This study is testing how well the drug filgotinib works and how safe it is for Korean adults with rheumatoid arthritis who haven't gotten enough relief from other standard medications. About 118 participants will take filgotinib for 24 weeks, and researchers will measure improve…
Phase: PHASE4 • Sponsor: Eisai Korea Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC